SCHEMBL753447

SCHEMBL753447

Cc1ccc(-p2c3cc4ccccc4cc3c3cc4c(cc32)c2cc3ccccc3cc2p4-c2ccc(C)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 4/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ CYP1A2 P05177 5/20 0.34
▸ NQO1 P15559 1/20 0.34
▸ TSHR P16473 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 3/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ KMT2A Q03164 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL753460 0.96 CYP2A6 (0.39) CYP2A6TDP1CYP1A2NQO1TSHR
SCHEMBL13674217 0.79 ALDH1A1 (0.31) TDP1ALDH1A1CYP3A4HSD17B10
SCHEMBL13669858 0.78 ALDH1A1 (0.34) CYP2A6TDP1CYP1A2NQO1TSHR
SCHEMBL753462 0.75 ALDH1A1 (0.35) TDP1CYP1A2ALDH1A1CYP3A4HPGD
SCHEMBL12873463 0.74 ESR1 (0.44) ACHE
SCHEMBL16807747 0.74 HTR2A (0.43) ALDH1A1CYP3A4HSD17B10LMNAACHE
SCHEMBL13443227 0.71 CYP2A6 (0.48) CYP2A6TDP1CYP1A2TSHRALDH1A1
SCHEMBL753449 0.71 NQO1 (0.41) CYP2A6TDP1CYP1A2NQO1TSHR
SCHEMBL13502052 0.71 KIF11 (0.38) CYP2A6TDP1CYP1A2TSHRALDH1A1
SCHEMBL18566171 0.71 GPR3 (0.44) TSHRALDH1A1HPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586972-B2 Organic thin film transistor, organic semiconductor thin film, and organic semiconductor material FUJIFILM CORPORATION (JP) 2017-03-07 — — US disclosed
US-8138355-B2 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same TOSOH CORPORATION (JP) 2012-03-20 — — US disclosed
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME AS3MT, TERT, TEAD1 CYP2A6 880/4885TDP1 2059/4885CYP1A2 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback